Mr. Ronald Loucks reports

NEXGENRX ANNOUNCES DECLARATION OF DIVIDEND

NexgenRx Inc. has declared a dividend in the amount of one-half of one cent per share (0.5 cent) in respect of all of its outstanding common shares and Series 1 preferred shares. This dividend will be payable on or before June 30, 2023, to all shareholders of record as at the close of business on June 23, 2023. As of the date of this press release, there are a total of 70,335,883 common shares and 6.6 million Series 1 preferred shares issued and outstanding. The common shares are listed and posted for trading on the TSX Venture Exchange under the symbol NXG. The Series 1 preferred shares are not listed or posted for trading on any stock exchange.

About NexgenRx Inc.

NexgenRx is Canada's only independent full-service third party administrator and technology solutions provider, offering proprietary full front-end, eligibility, enrolment, hour bank and mobile access capabilities, together with state-of-the-art claims adjudication and full provider network coverage. These combined capabilities allow NexgenRx to provide plan sponsors, sophisticated administration and health benefit technology applications in a cost-effective SaaS (software-as-a-service) model.

NexgenRx is committed to building partnerships with organizations looking to exceed the expectations of their clients and plan members, and deliver superior administration and claims processing solutions at a competitive cost.

We seek Safe Harbor.